STAFF PROFILE
Professor Ross Vlahos
Position:
Deputy Dean, Research & Innovation
College / Portfolio:
STEM College
School / Department:
STEM|Health and Biomedical Sciences
Phone:
+61399257362
Email:
ross.vlahos@rmit.edu.au
Campus:
Bundoora West
Contact me about:
Research supervision
- De Luca, S.,Chan, S.,Dobric, A.,Wang, H.,Seow, H.,Brassington, K.,Mou, K.,Alateeq, R.,Akhtar, A.,Bozinovski, S.,Vlahos, R. (2023). Cigarette smoke-induced pulmonary impairment is associated with social recognition memory impairments and alterations in microglial profiles within the suprachiasmatic nucleus of the hypothalamus In: Brain, Behaviour and Immunity, 109, 292 - 307
- Strachan, J.,Dyett, B.,Chan, S.,McDonald, B.,Vlahos, R.,Valery, C.,Conn, C. (2023). A promising new oral delivery mode for insulin using lipid-filled enteric-coated capsules In: Biomaterials Advances, 148, 1 - 10
- Chan, S.,Brassington, K.,Almerdasi, S.,Dobric, A.,De Luca, S.,Coward-Smith, M.,Wang, H.,Mou, K.,Akhtar, A.,Alateeq, R.,Wang, W.,Seow, H.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2023). Inhibition of oxidative stress by apocynin attenuated chronic obstructive pulmonary disease progression and vascular injury by cigarette smoke exposure In: British Journal of Pharmacology, 180, 2018 - 2034
- Fung, N.,Wang, H.,Vlahos, R.,Wilson, N.,Lopez, A.,Owczarek, C.,Bozinovski, S. (2022). Targeting the human ßc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure In: Respirology, 27, 617 - 629
- Brassington, K.,Chan, S.,De Luca, S.,Dobric, A.,Almerdasi, S.,Mou, K.,Seow, H.,Oseghale, S.,Bozinovski, S.,Selemidis, S.,Vlahos, R. (2022). Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice In: Clinical Science, 136, 537 - 555
- Brassington, K.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2022). Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics In: Clinical Science, 136, 405 - 423
- Ruwanpura, S.,McLeod, L.,Dousha, L.,Bozinovski, S.,Vlahos, R., et al., . (2022). Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1ß axes bridge innate immunity and epithelial apoptosis to promote emphysema In: Proceedings of the National Academy of Sciences of the United States of America, 119, 1 - 12
- Erlich, J.,To, E.,Luong, R.,Liong, F.,Liong, S.,Oseghale, O.,Miles, M.,Bozinovski, S.,Vlahos, R.,Chan, S.,Selemidis, S., et al., . (2022). Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-ß-Dependent Inflammation in Macrophages In: Antioxidants, 11, 1 - 14
- Oseghale, S.,Liong, S.,Coward-Smith, M.,To, E.,Erlich, J.,Selemidis, S.,Liong, F.,Miles, M.,Norouzi, S.,Vlahos, R.,Bozinovski, S., et al, . (2022). Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice In: PLoS Pathogens, 18, 1 - 21
- Oseghale, O.,Vlahos, R.,O’Leary, J.,Brooks, R.,Brooks, D.,Liong, S.,Selemidis, S. (2022). Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications In: Viruses, 14, 1 - 22
11 PhD Completions and 1 Masters by Research Completions8 PhD Current Supervisions
Asthma, Chronic obstructive pulmonary disease, Lung inflammation, Oxidative stress, Respiratory infections, Emphysema
- RMIT/Northern Heath Clinical Translational Research Partnership (Head Agreement). Funded by: Northern Health - Contract from (2024 to 2027)
- A flow cytometry suite for multiscale biosorting (externally led by Latrobe University). Funded by: ARC Linkage Infrastructure Equipment and Facilities (LIEF) Grant from (2022 to 2023)
- New ways to treat vascular cognitive impairment and dementia in chronic lung disease . Funded by: Lung Foundation Australia Grant 2014 onwards from (2021 to 2023)
- Targeting oxidant-dependent pathways to treat skeletal muscle wasting in COPD. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2024)
- FPR2 is a therapeutic target in lung cancer. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2022)